Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting
Sphingosine kinases 1 and 2 (SK1 and SK2) are proto-oncogenic isozymes expressed in many human tumors and associated with chemoresistance and poor prognosis. They are well-recognized therapy targets and their inhibition was shown to induce tumor volume reduction and chemosensitization in multiple ca...
Main Authors: | Heba Alshaker, Qi Wang, Daniel Brewer, Dmitri Pchejetski |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00303/full |
Similar Items
-
Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target
by: Heba Alshaker, et al.
Published: (2020-03-01) -
Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
by: Yonghua Bao, et al.
Published: (2017-10-01) -
Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
by: Preeti Gupta, et al.
Published: (2021-04-01) -
Sphingosine Kinase-1 Involves the Inhibitory Action of HIF-1α by Chlorogenic Acid in Hypoxic DU145 Cells
by: Myoung-Sun Lee, et al.
Published: (2017-02-01) -
A real-time high-throughput fluorescence assay for sphingosine kinases
by: Santiago Lima, et al.
Published: (2014-07-01)